- development of novel treatment modalities for solid cancers (photodynamic therapy, phytochemicals-based chemotherapy, targeted liposomal drug delivery systems) - mechanistic studies on hepatic ischemia/reperfusion injury (glycocalyx degradation, sterile inflammation, oxidative and nitrosative stress, primary and secondary hemostasis) - development of intervention modalities for liver diseases and conditions (cholestasis and cholangiocarcinomas, steatosis, liposome-based intervention strategies) - development of targeted nanoparticluate probe delivery systems for intravital determination of oxidative/nitrosative stress and mitochondrial depolarization
Effective start/end date01/05/2013 → …

ID: 176055